Prescription drug · NDA
Cystadane (Betaine) NDC 52276-400
Betaine 1 g/g · Powder, For solution · Oral · Recordati Rare Diseases
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52276-400-01 | 52276040001 | 180 g in 1 BOTTLE (52276-400-01)Marketed from Apr 13, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cystadane
- Generic name (nonproprietary)
- betaine
- Active ingredients
- Betaine — 1 g/g
- Dosage form
- Powder, For solution
- Route
- Oral
- Labeler
- Recordati Rare DiseasesNDC labeler code 52276
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020576
- Marketing start
- Listing expires
- Other FDA classes
- Methylating Activity (Mechanism)
- Identifiers
- Product ID 52276-400_3a4fdd66-b72b-4aa3-94bb-bac8af98b150SPL ID 3a4fdd66-b72b-4aa3-94bb-bac8af98b150SPL set ID 31a684d0-cd98-4e46-b43a-ccbd17c41559RxCUI 404539, 562847UNII 3SCV180C9W
- Pharmacologic class
- Methylating Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452276040001followed by a unit qualifier and the quantityPackage 52276-0400-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
CYSTADANE ® is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations in pediatric and adult patients. Included within the category of homocystinuria are: Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect CYSTADANE is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations. Included within the category of homocystinuria are ( 1 ): Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor me…
Excerpt only. Read the full label for complete information.
About NDC 52276-400
- What is NDC 52276-400?
- 52276-400 is the product NDC for Cystadane (betaine), Betaine 1 g/g powder, for solution, listed with the FDA by Recordati Rare Diseases. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cystadane (Betaine).
- What is the active ingredient?
- Betaine.
- Who is the labeler?
- Recordati Rare Diseases, NDC labeler code 52276. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cystadane?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.